{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:58:52Z","timestamp":1793505532930,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Healthy Longevity"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lanhl.2025.100796","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T19:55:46Z","timestamp":1763841346000},"page":"100796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bridging the age gap: improving representation of older adults in clinical trials for type 2 diabetes and chronic kidney disease"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-9159","authenticated-orcid":false,"given":"Changyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Chepulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Rossi","family":"Varallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidra C","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Vart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanhl.2025.100796_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s43856-021-00029-9","article-title":"An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes","volume":"1","author":"Hanlon","year":"2021","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.lanhl.2025.100796_bib3","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s40520-022-02165-1","article-title":"Prevalence and impact of polypharmacy in older patients with type 2 diabetes","volume":"34","author":"Remelli","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.lanhl.2025.100796_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/imj.15759","article-title":"Frailty in chronic kidney disease: challenges in nephrology practice. A review of current literature","volume":"53","author":"Kennard","year":"2023","journal-title":"Intern Med J"},{"key":"10.1016\/j.lanhl.2025.100796_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36149","article-title":"Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010 through 2019","volume":"5","author":"Lau","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanhl.2025.100796_bib6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamainternmed.2019.1501","article-title":"Representativeness of randomized clinical trial cohorts in end-stage kidney disease: a meta-analysis","volume":"179","author":"Smyth","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ndt\/gfae071","article-title":"A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population","volume":"40","author":"Forbes","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lanhl.2025.100796_bib8","first-page":"e253","article-title":"How applicable are clinical practice guidelines to elderly patients with comorbidities?","volume":"57","author":"Mutasingwa","year":"2011","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.lanhl.2025.100796_bib9","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanhl.2025.100796_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/jcm13020348","article-title":"Chronic kidney disease in the older adult patient with diabetes","volume":"13","author":"Ravender","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1017\/S0266462303000199","article-title":"Connecting pre-marketing clinical research and medical practice: opinion-based study of core issues and possible changes in drug regulation","volume":"19","author":"Wieringa","year":"2003","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.lanhl.2025.100796_bib12","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/S2666-7568(23)00210-6","article-title":"Age disparities in glucose-lowering treatment for Danish people with type 2 diabetes: a cross-sectional study between 2019 and 2020","volume":"4","author":"Johansson","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.lanhl.2025.100796_bib13","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.9778\/cmajo.20210281","article-title":"Use of sodium-glucose cotransporter 2 inhibitors in Alberta adults with chronic kidney disease: a cross-sectional study identifying care gaps to inform knowledge translation","volume":"11","author":"Lau","year":"2023","journal-title":"CMAJ Open"},{"key":"10.1016\/j.lanhl.2025.100796_bib14","year":"2022"},{"key":"10.1016\/j.lanhl.2025.100796_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2215\/CJN.05960521","article-title":"Patient and caregiver experiences and attitudes about their involvement in research in chronic kidney disease","volume":"17","author":"Gutman","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.lanhl.2025.100796_bib16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/jgs.18857","article-title":"Attitudes on participation in clinical drug trials: a nationally representative survey of older adults with multimorbidity","volume":"72","author":"Schwartz","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lanhl.2025.100796_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40266-014-0168-2","article-title":"Attitudes of older adults to their participation in clinical trials: a pilot study","volume":"31","author":"Bloch","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.lanhl.2025.100796_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s13063-023-07506-7","article-title":"Why do older adults decline participation in research? Results from two deprescribing clinical trials","volume":"24","author":"Strayer","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.lanhl.2025.100796_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/NNR.0000000000000406","article-title":"Recruitment of older kidney transplant recipients to a longitudinal study","volume":"69","author":"O\u2019Brien","year":"2020","journal-title":"Nurs Res"},{"key":"10.1016\/j.lanhl.2025.100796_bib20","article-title":"Prevalence of cognitive impairment and its predictors among chronic kidney disease patients: a systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.lanhl.2025.100796_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00592-020-01648-9","article-title":"The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis","volume":"58","author":"You","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.lanhl.2025.100796_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.1984.03350070043021","article-title":"Competency to give an informed consent. A model for making clinical assessments","volume":"252","author":"Drane","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.lanhl.2025.100796_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/pcn.12289","article-title":"Informed consent procedures with cognitively impaired patients: a review of ethics and best practices","volume":"69","author":"Fields","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.lanhl.2025.100796_bib24","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/jgs.16875","article-title":"Recruitment and retention of older people in clinical research: A systematic literature review","volume":"68","author":"Forsat","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lanhl.2025.100796_bib25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.socscimed.2008.12.025","article-title":"Barriers to clinical research participation in a diabetes randomized clinical trial","volume":"68","author":"Robiner","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib26","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/ageing\/afab147","article-title":"Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials","volume":"50","author":"Buttgereit","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.lanhl.2025.100796_bib27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/dom.16137","article-title":"Exclusion of older persons from randomized controlled trials in type 2 diabetes: a cross-sectional study","volume":"27","author":"Borysowski","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.lanhl.2025.100796_bib28","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/S2666-7568(22)00186-6","article-title":"Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43\u2009895 trials and 5\u2009685\u2009738 individuals across 989 unique drugs and 286 conditions in England","volume":"3","author":"Tan","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.lanhl.2025.100796_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106683","article-title":"Age-based exclusions in clinical trials: a review and new perspectives","volume":"114","author":"Nguyen","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.lanhl.2025.100796_bib30","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/TP.0b013e31820f42d9","article-title":"Age, exclusion criteria, and generalizability of randomized trials enrolling kidney transplant recipients","volume":"91","author":"Blosser","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.lanhl.2025.100796_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/jgs.12215","article-title":"Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus","volume":"61","author":"Cruz-Jentoft","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lanhl.2025.100796_bib32","first-page":"41","article-title":"The challenges of enrolling older adults into intervention studies","volume":"86","author":"Knechel","year":"2013","journal-title":"Yale J Biol Med"},{"issue":"suppl 1","key":"10.1016\/j.lanhl.2025.100796_bib33","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2105\/AJPH.2009.162982","article-title":"Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change","volume":"100","author":"Herrera","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.lanhl.2025.100796_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40900-016-0050-y","article-title":"Exploring the motivations of patients with type 2 diabetes to participate in clinical trials: a qualitative analysis","volume":"2","author":"Estcourt","year":"2016","journal-title":"Res Involv Engagem"},{"key":"10.1016\/j.lanhl.2025.100796_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/dom.14013","article-title":"Evaluating glucose-lowering treatment in older people with diabetes: lessons from the IMPERIUM trial","volume":"22","author":"Sinclair","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.lanhl.2025.100796_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004553","article-title":"Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: an individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events","volume":"22","author":"Wightman","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12889-024-18036-5","article-title":"Barriers and facilitators to health technology adoption by older adults with chronic diseases: an integrative systematic review","volume":"24","author":"Bertolazzi","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lanhl.2025.100796_bib38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0140-6736(23)00876-0","article-title":"Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (Thomas): a prospective, randomised, open-label implementation study","volume":"402","author":"Van Mil","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lanhl.2025.100796_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae007","article-title":"Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach","volume":"53","author":"Hag\u00e8ge","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.lanhl.2025.100796_bib40","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1016\/S2666-7568(23)00234-9","article-title":"Diabetes care in older people: a call for action","volume":"4","author":"Muskiet","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.lanhl.2025.100796_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2165\/11591990-000000000-00000","article-title":"Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study","volume":"28","author":"Crome","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.lanhl.2025.100796_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ageing\/afr115","article-title":"Improving recruitment of older people to research through good practice","volume":"40","author":"McMurdo","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.lanhl.2025.100796_bib43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMe078023","article-title":"Clinical trials in the elderly--a concept comes of age","volume":"356","author":"Siu","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12875-018-0736-3","article-title":"General practitioners\u2019 perspectives on management of early-stage chronic kidney disease: a focus group study","volume":"19","author":"van Dipten","year":"2018","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.lanhl.2025.100796_bib45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ajag.13234","article-title":"International responses addressing the under-representation of older people in clinical research","volume":"42","author":"Markham","year":"2023","journal-title":"Australas J Ageing"},{"key":"10.1016\/j.lanhl.2025.100796_bib47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S2213-8587(25)00168-8","article-title":"Underrepresentation of older adults in diabetes and kidney disease trials","volume":"13","author":"Vart","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.lanhl.2025.100796_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2025.100582","article-title":"Enhancing the methodology of clinical trials in older people: a scoping review with global perspective","volume":"29","author":"Cesari","year":"2025","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.lanhl.2025.100796_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104304","article-title":"The impact of operational trial approaches on representativeness: comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice","volume":"30","author":"de Jong","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.lanhl.2025.100796_bib50","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1681\/ASN.2015111264","article-title":"Pragmatic clinical trials in CKD: opportunities and challenges","volume":"27","author":"de Boer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lanhl.2025.100796_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.xkme.2021.08.001","article-title":"Trends in adaptive design methods in dialysis clinical trials: a systematic review","volume":"3","author":"Judge","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103474","article-title":"Hierarchical composite endpoints in clinical trials for multimorbid older adults","volume":"88","author":"Vart","year":"2025","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.lanhl.2025.100796_bib53","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1681\/ASN.0000000000000244","article-title":"Validity and utility of a hierarchical composite end point for clinical trials of kidney disease progression: a review","volume":"34","author":"Little","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lanhl.2025.100796_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s13063-016-1589-5","article-title":"Recruitment of older adults with type 2 diabetes into a community-based exercise and nutrition randomised controlled trial","volume":"17","author":"Miller","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.lanhl.2025.100796_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dom.13051","article-title":"Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: a randomized, controlled stUdy in type 2 diabetes mellitus (IMPERIUM)","volume":"20","author":"Heller","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.lanhl.2025.100796_bib56","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/0145721708325764","article-title":"Effective recruitment and retention strategies for older members of rural minorities","volume":"34","author":"Burns","year":"2008","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.lanhl.2025.100796_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/geront\/gnae188","article-title":"Strategies to improve research participation by older people with cognitive impairment: a systematic review","volume":"65","author":"Swan","year":"2025","journal-title":"Gerontologist"},{"key":"10.1016\/j.lanhl.2025.100796_bib58","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/gerona\/glz112","article-title":"Comparison of recruitment strategies for engaging older minority adults: results from take heart","volume":"75","author":"Ramsay","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.lanhl.2025.100796_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025580","article-title":"Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review","volume":"9","author":"Bracken","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanhl.2025.100796_bib60","first-page":"78","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lanhl.2025.100796_bib61","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib62","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanhl.2025.100796_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.conctc.2018.05.003","article-title":"Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial","volume":"11","author":"O\u2019Hare","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.lanhl.2025.100796_bib65","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/07334648211072537","article-title":"\u201cGetting There\u201d: transportation as a barrier to research participation among older adults","volume":"41","author":"Rigatti","year":"2022","journal-title":"J Appl Gerontol"},{"key":"10.1016\/j.lanhl.2025.100796_bib66","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/j.1532-5415.2008.02015.x","article-title":"Recruitment and retention of older adults in aging research","volume":"56","author":"Mody","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.lanhl.2025.100796_bib67","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/cts.2024.3","article-title":"Narrative review of telemedicine applications in decentralized research","volume":"8","author":"Cummins","year":"2024","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.lanhl.2025.100796_bib68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jclinepi.2011.04.011","article-title":"Telephone interviews can be used to collect follow-up data subsequent to no response to postal questionnaires in clinical trials","volume":"65","author":"Lall","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lanhl.2025.100796_bib69","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archpsyc.62.7.726","article-title":"Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument","volume":"62","author":"Palmer","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lanhl.2025.100796_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.614149","article-title":"Design and feasibility of a randomized controlled pilot trial to reduce exposure and cognitive risk associated with advanced glycation end products in older adults with type 2 diabetes","volume":"8","author":"Lotan","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.lanhl.2025.100796_bib71","article-title":"Effects of dapagliflozin on health-related quality of life in patients with CKD","author":"Bakker","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lanhl.2025.100796_bib72","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/ndt\/gfaf046","article-title":"Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease","volume":"40","author":"Bakker","year":"2025","journal-title":"Nephrol Dial Transplant"}],"container-title":["The Lancet Healthy Longevity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666756825001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666756825001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:25:20Z","timestamp":1773969920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666756825001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666756825001151"],"URL":"https:\/\/doi.org\/10.1016\/j.lanhl.2025.100796","relation":{},"ISSN":["2666-7568"],"issn-type":[{"value":"2666-7568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the age gap: improving representation of older adults in clinical trials for type 2 diabetes and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Healthy Longevity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanhl.2025.100796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100796"}}